ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

3 Stocks Under $50 That Concern Us

PRDO Cover Image

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.

This is precisely where StockStory comes in - we do the heavy lifting to identify companies with solid fundamentals so you can invest with confidence. Keeping that in mind, here are three stocks under $50 to swipe left on and some alternatives you should look into instead.

Perdoceo Education (PRDO)

Share Price: $28.71

Formerly known as Career Education Corporation, Perdoceo Education (NASDAQ: PRDO) is an educational services company that specializes in postsecondary education.

Why Do We Steer Clear of PRDO?

  1. Muted 3.7% annual revenue growth over the last five years shows its demand lagged behind its consumer discretionary peers
  2. Earnings growth underperformed the sector average over the last five years as its EPS grew by just 10.8% annually
  3. Diminishing returns on capital suggest its earlier profit pools are drying up

At $28.71 per share, Perdoceo Education trades at 38.3x forward EV-to-EBITDA. Read our free research report to see why you should think twice about including PRDO in your portfolio.

Supernus Pharmaceuticals (SUPN)

Share Price: $45.68

With a diverse portfolio of eight FDA-approved medications targeting neurological conditions, Supernus Pharmaceuticals (NASDAQ: SUPN) develops and markets treatments for central nervous system disorders including epilepsy, ADHD, Parkinson's disease, and migraine.

Why Is SUPN Risky?

  1. Annual revenue growth of 5.9% over the last five years was below our standards for the healthcare sector
  2. Subscale operations are evident in its revenue base of $681.5 million, meaning it has fewer distribution channels than its larger rivals
  3. Eroding returns on capital from an already low base indicate that management’s recent investments are destroying value

Supernus Pharmaceuticals is trading at $45.68 per share, or 17.9x forward P/E. To fully understand why you should be careful with SUPN, check out our full research report (it’s free for active Edge members).

Peoples Bancorp (PEBO)

Share Price: $31.29

Founded in 1902 in Ohio and expanding through both organic growth and acquisitions, Peoples Bancorp (NASDAQ: PEBO) is a financial holding company that provides banking, insurance, equipment leasing, and investment services to consumers and businesses.

Why Does PEBO Worry Us?

  1. 5.9% annual revenue growth over the last two years was slower than its banking peers
  2. Net interest margin shrank by 44.7 basis points (100 basis points = 1 percentage point) over the last two years, suggesting the profitability of its loan book is decreasing or the market is becoming more competitive
  3. Earnings per share fell by 13.5% annually over the last two years while its revenue grew, showing its incremental sales were much less profitable

Peoples Bancorp’s stock price of $31.29 implies a valuation ratio of 0.9x forward P/B. Check out our free in-depth research report to learn more about why PEBO doesn’t pass our bar.

High-Quality Stocks for All Market Conditions

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  228.43
+0.00 (0.00%)
AAPL  270.97
+0.00 (0.00%)
AMD  214.95
+0.00 (0.00%)
BAC  55.88
+0.00 (0.00%)
GOOG  311.33
+0.00 (0.00%)
META  661.50
+0.00 (0.00%)
MSFT  484.92
+0.00 (0.00%)
NVDA  183.60
-0.09 (-0.05%)
ORCL  198.38
+0.00 (0.00%)
TSLA  489.08
+0.35 (0.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.